The inactivation produces cytoskeletal conformational changes that decrease the PI3K/Akt/Bcl-2 signaling [20] resulting in several biologic effects, such as inhibition of interleukin (IL)-10 and increase of AML cells chemosensitivity. Here, BCL2 is linked to acute myeloid leukemia.